Tone mix
Week by week 52 weeks
Share of Crescent Biopharma, Inc. Common Stock's 99 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Aug 3, 2026 · tone -100Crescent Biopharma (NASDAQ:CBIO) Releases Quarterly Earnings Results, Misses Expectations By $0.04 EPS-106
- Week of Nov 10, 2025 · tone -100Crescent Biopharma (NASDAQ:CBIO) Releases Quarterly Earnings Results, Misses Estimates By $0.26 EPS-100
- Week of Aug 24, 2026 · tone +100Wedbush Reiterates "Outperform" Rating for Crescent Biopharma (NASDAQ:CBIO)+86
- Week of Sep 28, 2026 · tone +98Crescent Biopharma Announces Grants of Inducement Awards+83
- Week of Nov 17, 2025 · tone +98Crescent Biopharma Announces Grants of Inducement Awards+79
- Week of Jul 20, 2026 · tone +99Crescent Biopharma Announces Grants of Inducement Awards+75
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Crescent Biopharma, Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 0 | No headlines |
| Last 30 sessions | 9 | +44 |
| Last 90 sessions | 30 | +20 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Wednesday, October 7, 2026
1 headline, average tone +98: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletCrescent Biopharma Announces Grants of Inducement AwardsPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Crescent Biopharma Announces Grants of Inducement Awards | www.manilatimes.net | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 6, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.rttnews.com · 1 outletCrescent Biopharma Gets FDA Clearance For Next-Gen Cancer ADC CR-002Positive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Crescent Biopharma Gets FDA Clearance For Next-Gen Cancer ADC CR-002 | www.rttnews.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 5, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.finanzen.ch · 1 outletCrescent Biopharma Gets FDA Clearance For Next-Gen Cancer ADC CR-002Positive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Crescent Biopharma Gets FDA Clearance For Next-Gen Cancer ADC CR-002 | www.finanzen.ch | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Monday, September 28, 2026
1 headline, average tone +98: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletCrescent Biopharma Announces Grants of Inducement AwardsPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Crescent Biopharma Announces Grants of Inducement Awards | www.manilatimes.net | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Monday, September 21, 2026
5 headlines, average tone 0: 0 positive, 5 neutral and 0 negative. Showing all 5.
- www.dailypolitical.com · 1 outletHead to Head Contrast: Vir Biotechnology (NASDAQ:VIR) vs. Crescent Biopharma (NASDAQ:CBIO)Neutral
- www.themarketsdaily.com · 1 outletAnalyzing Crescent Biopharma (NASDAQ:CBIO) and XTL Biopharmaceuticals (NASDAQ:XTLB)Neutral
- www.themarketsdaily.com · 1 outletCrescent Biopharma (NASDAQ:CBIO) COO Sells 3,839 Shares of StockNeutral
- www.dailypolitical.com · 1 outletCrescent Biopharma (NASDAQ:CBIO) Insider Sells 658 Shares of StockNeutral
- www.tickerreport.com · 1 outletJan Pinkas Sells 658 Shares of Crescent Biopharma (NASDAQ:CBIO) StockNeutral
Show the table · 5 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Head to Head Contrast: Vir Biotechnology (NASDAQ:VIR) vs. Crescent Biopharma (NASDAQ:CBIO) | www.dailypolitical.com | 1 | Neutral |
| Analyzing Crescent Biopharma (NASDAQ:CBIO) and XTL Biopharmaceuticals (NASDAQ:XTLB) | www.themarketsdaily.com | 1 | Neutral |
| Crescent Biopharma (NASDAQ:CBIO) COO Sells 3,839 Shares of Stock | www.themarketsdaily.com | 1 | Neutral |
| Crescent Biopharma (NASDAQ:CBIO) Insider Sells 658 Shares of Stock | www.dailypolitical.com | 1 | Neutral |
| Jan Pinkas Sells 658 Shares of Crescent Biopharma (NASDAQ:CBIO) Stock | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Crescent Biopharma, Inc. Common Stock, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.